Increased Osteopontin Levels in the Cerebrospinal Fluid of Patients With Multiple Sclerosis
Authors:
- Robert NunanRNRobert Nunan
- Graham NiepelGNGraham Niepel
- Laura J. EdwardsLELaura J. Edwards
- Cris S. ConstantinescuCris S. Constantinescu
Open Access
- 1 May 2008
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 65 (5) , 633-635
Abstract
Proinflammatory cytokines and T cells reactive against myelin proteins play an important role in the pathogenesis of multiple sclerosis (MS) and its experimental model, experimental autoimmune encephalomyelitis (EAE).1,2Keywords
This publication has 14 references indexed in Scilit:
- Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cellsNature Immunology, 2006
- Up‐regulation of osteopontin and αΒ‐crystallin in the normal‐appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarraysNeuropathology and Applied Neurobiology, 2005
- Plasma osteopontin levels in multiple sclerosisJournal of Neuroimmunology, 2005
- Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune DiseaseArchives of Neurology, 2004
- Osteopontin levels and increased disease activity in relapsing–remitting multiple sclerosis patientsJournal of Neuroimmunology, 2004
- Elevated osteopontin levels in active relapsing‐remitting multiple sclerosisAnnals of Neurology, 2003
- Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for TherapyAnnual Review of Neuroscience, 2002
- The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating DiseaseScience, 2001
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- Rating neurologic impairment in multiple sclerosisNeurology, 1983